420 with CNW — German Marijuana Club Hands Out Legal Cannabis as Pilot Program Kicks Off

Germany recently saw its first cannabis social club—Social Club Ganderkesee—announce the distribution of cannabis to its members, marking a new milestone in the country’s journey toward regulated marijuana access. The nation legalized the possession and personal cultivation of marijuana for adults in April. However, until recently, there were limited legal means for acquiring the substance.

Social Club Ganderkesee started growing cannabis in July after receiving a permit from Lower Saxony’s Agriculture Minister, Miriam Staudte. According to Daniel Keune, the club’s chairman, the membership represents a broad demographic, ranging from 18 to 70 years old. Each social club is restricted to 500 members, and each member can purchase up to 50 grams of cannabis per month.

Lawmaker Carmen Wegge of the Social Democratic Party (SPD) emphasized the importance of the clubs in assisting in the reduction of the illicit marijuana market. She noted that the clubs offer a valuable option for people who may not want to grow cannabis on their own.

Meanwhile, cities like Frankfurt and Hanover are advancing separate pilot programs aimed at widening access to cannabis in controlled ways over the next five years. Frankfurt’s program would enable controlled commercial sales of cannabis to a group of selected participants. The initiative would allow individuals to buy up to 25 grams daily, with a cap of 50 grams per month, from four authorized shops throughout the city.

Participants would need to commit to health monitoring through evaluations and surveys conducted by medical professionals. However, people with certain conditions—such as mental health issues, those who are pregnant or breastfeeding, and minors—would not be eligible for the program. The program aims to offer legal cannabis at competitive prices, ideally to reduce reliance on the black market, where prices often range from €8 to €10 ($8.59-$10.74).

Meanwhile, Hanover’s program would avail cannabis through pharmacies for around 4,000 residents. Belit Onay, Hanover’s Mayor, stated that the project is intended to address the reality of marijuana use in the community while mitigating the risks associated with illegal markets. Marijuana is expected to be available under this program by next year.

Germany’s cannabis reform is expected to unfold in two phases. The initial phase involves personal possession, cultivation, and the establishment of social clubs. The second phase, which is still in development, is expected to introduce a comprehensive commercial cannabis sales model.

Karl Lauterbach, the Health Minister and a key advocate for legalization, has indicated that the government is carefully considering the second part of the law. As legalization progresses, there is growing public and political pressure to accelerate the timeline for broader commercial access.

Companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) with an eye on expanding their international footprint are likely to monitor the developments in Germany to see if any opportunities open up.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — New Study Says Approximately 6% of Pregnant Women Use Cannabis

Six percent of women reported using cannabis while pregnant, according to a recent study, despite studies indicating that using cannabis during pregnancy can be harmful to both the fetus and the expectant mother.

Researchers from the University of Georgia found this concerning as it suggests more than one in every 20 pregnancies may be affected by marijuana use. Most women surveyed seemed to perceive cannabis as a harmless remedy and have turned to it to manage symptoms like morning sickness.

According to the study’s lead author, Mohammad Haider, using cannabis for nausea during pregnancy is risky. He emphasized that this isn’t a safe solution for expectant mothers. The study analyzed data from federal surveys of 4,338 expectant women. Of those surveyed, around 5.7% reported using marijuana in the previous month.

The findings indicated that marijuana use among pregnant women is highest during the first trimester and declines as pregnancy advances, likely suggesting its use as a response to early pregnancy nausea. Interestingly, a large portion of these women—around 71%—believed that their marijuana use posed little or no risk to themselves or their babies. However, previous research has linked cannabis use in pregnancy to premature delivery, low weight at birth, and developmental issues in children.

The study also pointed out that two-thirds of the pregnant women who reported using marijuana lived in one of the states where medical cannabis is legal. Haider noted that the accessibility of marijuana in these states could unintentionally contribute to its use during pregnancy.

He explained that when medical cannabis is legally available in pharmacies, it becomes more accessible, which may lead pregnant women to use it without fully understanding the potential dangers. He suggested that states with legal access to medical cannabis should implement policies that educate pregnant women on the possible negative effects of cannabis use during pregnancy.

Haider and his research team noted that safer, prescribed medications are available to alleviate morning sickness. They recommended that women consult their healthcare providers to explore alternatives before considering cannabis. Additionally, Haider highlighted that women with a history of mental health issues or substance use may be more likely to turn to cannabis while pregnant, putting them and their babies at further risk.

“This is a vulnerable group,” Haider stated, “and research shows that cannabis use during pregnancy can be harmful to both child and mother.” He added that more state-level policies are needed to guide and inform women about the potential risks associated with marijuana use during pregnancy.

As pressure mounts to make even more federal regulatory changes to marijuana policies, industry actors like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) will find it easier to conduct studies geared at giving patients more targeted information about how best to benefit from their products while keeping risks minimal.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Recreational Marijuana Measure Attracts Heavy Funding on Both Sides in South Dakota

The financial race surrounding the recreational marijuana legalization initiative in South Dakota was highly competitive, with both opponents and supporters gathering nearly equal resources. This set the scene for an intense debate while voters prepared for the November 5 ballot. Both sides have collectively raised around $915,000, showcasing the deeply split opinions across the state on the matter.

Advocates for Initiated Measure 29, which aims to legalize the use and sale of cannabis for those aged 21 and over, have secured about $458,000 in funding. The main group pushing for the measure, known as the Yes on 29 Ballot Committee, has raised $436,000, with $300,000 contributed by cannabis-related businesses. The largest single donation was $100,000 from GL Partners, a Rapid City-based medical cannabis dispensary.

On the opposing front, the Protecting SD Kids Ballot Question Committee accumulated about $457,000. A large share of this funding came from individual contributions, including a notable $61,400 donation by Brad Wheeler, a local manufacturer. Additionally, businesses within South Dakota collectively contributed $71,000 to the opposition’s campaign.

The significant financial backing on both sides highlights the importance of Initiated Measure 29, one of seven ballot measures voters will decide on this November. So far, the Yes on 29 campaign has spent approximately $217,000 on its advocacy efforts, while the opposition has spent a more substantial $371,000 on initiatives to prevent the measure’s approval.

The financial records show an ongoing trend where the marijuana industry heavily invests in efforts to support legalization measures across the country. Meanwhile, those against such measures often rely on local businesses and grassroots donations to bolster their campaigns.

As election day neared, the close fundraising figures signal a tight race. Both sides stepped up their campaigns to influence voters, aware of the potential long-term effects on South Dakota’s cannabis policy.

Neighboring states also contribute to the broader conversation about cannabis reform. Montana, for instance, has already seen more than $118 million in tax revenue from its legalized marijuana market over two years. North Dakota, looking at similar economic incentives, is proposing Measure 5, which promises job creation and financial gains. In contrast, Nebraska stands apart, lacking any legalization measures and emphasizing the varied regional perspectives on cannabis policy.

Without any restrictions on donation amounts, South Dakota’s campaign on this issue represents a significant and contentious vote, making November 5 a pivotal day for the state’s future approach to cannabis regulation.

Businesses like Innovative Industrial Properties Inc. (NYSE: IIPR) with interests in the cannabis space in other markets will be hoping that the will of the people wins the day once vote counting is completed.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Gallup Survey Finds US Bipartisan Majority Support for Cannabis Legalization Stable

Support for legalizing cannabis is showing consistent strength across the United States, according to a recent survey by Gallup. The findings highlight that a significant majority of Americans, regardless of political affiliation, continue to endorse marijuana reform.

The survey revealed a slight dip in support compared to last year’s figures, but the change falls within the margin of error and is not considered statistically significant, according to a Gallup representative. As voters head into elections where cannabis reform will appear on various state ballots, the poll indicates that 68% are in favor of legalization, while 31% remain opposed.

Breaking down the numbers by political groups, 85% of Democrats, 69% of Independents and 53% of Republicans support legalization. The survey also showed strong support across different age groups, with approval ranging from 74% among 18- to 29-year-olds to 56% among those 65 and over.

The 68% overall approval rate for cannabis legalization is a slight decrease from last year’s record-high 70%. Between 2020 and 2022, the level of support remained steady at 68%. The recent poll was conducted from October 1 to October 12 and involved 1,023 respondents, carrying a margin of error of ±4 percentage points.

In another survey released in August, Gallup found that the public perceives cannabis as less dangerous compared to substances like alcohol, vapes, and tobacco. It was also noted that more adults reported smoking cannabis compared to cigarettes.

Moreover, a 2020 poll highlighted that 70% of Americans consider smoking marijuana to be morally acceptable, a higher rate than for issues such as animal testing, gay relationships, and abortion.

In a separate set of polls conducted by YouGov in August, there was substantial support among likely voters in key swing states—Wisconsin, Michigan, and Pennsylvania—for various aspects of cannabis reform, including federal rescheduling, legalization, and access to banking services for the industry.

The strong and consistent support for cannabis reform has not gone unnoticed by presidential candidates. Both major presidential candidates—Kamala Harris and Donald Trump—have publicly supported legalization—a first in U.S. history.

Recent surveys show that a majority of marijuana users plan to vote for Kamala Harris, although around 40% have indicated they will support Trump. Harris recently stated that legalizing marijuana is a top priority on her agenda if she wins, reinforcing her previous commitment to pushing for federal legalization and ensuring legal access to cannabis.

Trump, meanwhile, has also shown support for cannabis initiatives, endorsing Florida’s ballot proposal to legalize cannabis and expressing approval for federal rescheduling and banking reform efforts.

Firms like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) are probably not surprised by the data on the big fraction of Americans who support marijuana legalization since this same process played out across the border in Canada, resulting in a country-wide policy change.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Fighters in Nevada Are No Longer Prohibited from Using Marijuana

The Nevada State Athletic Commission (NSAC) recently removed marijuana from its list of prohibited substances. This change means that fighters in the state who possess, use, or consume marijuana products will no longer face penalties for violating anti-doping rules.

For years, cannabis was classified as a banned substance, and fighters were often penalized if it was detected in their system. UFC fighters such as Trevin Jones, for example, have seen their victories overturned, changing their records to no-contests due to positive tests for marijuana.

Additionally, in 2015 popular fighter Nick Diaz received a severe penalty for marijuana use: a five-year suspension and a fine of $165,000. The NSAC explained that the severe punishment was due to Diaz’s perceived disregard for the commission’s rules, not solely for the marijuana use itself.

Many fans saw this penalty as excessive, especially since Diaz was at the peak of his career following a high-profile match against Anderson Silva. The suspension effectively sidelined him for six years, frustrating fans who believed he was unfairly targeted over a minor infraction.

Now, at age 41, Diaz continues to fight, though many fans feel he should retire due to his health and age. Cannabis, however, is no longer a barrier to his participation, as it is now fully permitted for MMA fighters in the state.

The policy shift is particularly relevant in Las Vegas, where the majority of UFC events are hosted, including Diaz’s forthcoming match at UFC 310 against Vicente Luque. Fighters beyond the Diaz brothers have also been open about their cannabis use, often citing its therapeutic benefits for managing pain and physical strain caused by their demanding sport.

There are still steps ahead before the policy is officially enacted, as the revised guidelines need another review by the state’s Legislative Counsel Bureau (LCB) to confirm they meet legal standards. After this, the state legislative commission, composed of six assembly members and six senators, will review the proposal and decide on its official adoption.

Other professional sports organizations at various levels have been reevaluating and updating their policies regarding marijuana in response to broader legalization efforts at the state level. For instance, the NCAA recently removed cannabis from its list of banned substances for Division I athletes.

Similarly, the UFC announced in December that it would formally remove cannabis from its updated list of banned substances, building upon previous reforms in this area.

The easing of restrictions against the use of marijuana by fighters and other athletes is a development that the wider marijuana industry, including entities like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), will be pleased about.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Kentucky’s First Lottery Selects 26 Businesses to Receive Medical Marijuana Licenses

Kentucky is making significant progress toward introducing medical cannabis as an option for healthcare in the state. Recently, 26 businesses were chosen to cultivate and process medical cannabis, which will soon be available for sale across Kentucky. The businesses earned their licenses through a random lottery held at the Kentucky Lottery office in Louisville.

Governor Andy Beshear expressed enthusiasm about the milestone, highlighting that all medical marijuana activities—from cultivation and processing to testing and dispensing—will occur within Kentucky. Further, he stated that the lottery was a step closer to providing safe and affordable access to medical marijuana for Kentuckians dealing with severe health conditions.

In his remarks, Beshear shared that the start date for patient access could be as soon as January 1 or shortly thereafter, as dispensaries and other necessary facilities begin operations. “A new day is approaching in Kentucky,” he noted, with safe, regulated medical cannabis soon available to support qualifying patients in managing their health conditions.

The Office of Medical Cannabis (OMC) executive director, Sam Flynn, shared that the state received 4,998 applications for business licenses related to medical cannabis, with 918 applicants aiming for processing and cultivation roles. Approximately 84% of these applications were approved for participation in the lottery.

Flynn further explained that the lottery approach was based on examining best practices in other states with established medical marijuana programs. “We prioritized creating a transparent and fair process from the start,” he added.

The lottery winners have fifteen days to pay their processing or cultivation license fees or risk losing the license. Once fees are paid, the OMC will officially grant the licenses, allowing businesses to start operations.

Under the program, cultivators will be required to grow cannabis in secure, locked facilities. They will then sell the harvested cannabis to processors, who will develop various medical cannabis products from the raw material.

A date for a separate lottery to award 48 dispensary licenses is expected to be announced on Thursday.

In September, the state took an initial step by awarding its first marijuana business license to a testing laboratory in Nicholasville. The facility is expected to examine products for safety and quality before they reach patients.

Eligible conditions include any form or stage of cancer; severe, chronic, or incapacitating pain; epilepsy or other chronic seizure disorders; post-traumatic stress disorder (PTSD); multiple sclerosis or associated muscle spasms; and chronic nausea or vomiting that resists conventional treatments.

The entire cannabis industry, including firms like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), will be hoping that the roll out of the medical marijuana program in Kentucky goes without a hitch and gives patients who need those products a chance to access them legally.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — New Jersey Marijuana Advocates Discuss the Possibility of Increasing the Fee for Social Equity

Advocates in New Jersey are currently debating whether the state’s Marijuana Regulatory Commission should raise the fee directing revenue from recreational cannabis sales to fund social equity initiatives and support communities affected by past drug policies. The commission is set to meet soon to determine the fee rate that will apply starting January 1. Presently, the fee is set at $1.24 per ounce.

Four years since New Jersey legalized recreational cannabis, some advocates argue that it is time to increase the fee to $30 per ounce. New Jersey has some of the lowest marijuana taxation in the nation, according to Marleina Ubel, a senior policy analyst at New Jersey Policy Perspective. She suggested that a cost of $30 would be practical and reasonable for companies.

Ubel stressed that the money raised by this tax is essential for the communities that were most negatively impacted by previous drug restrictions. She suggested that the revenue may be used to support after-school programs and other initiatives that would assist in reviving these areas.

The fee is a required part of the state’s cannabis legalization law and is collected based on the amount of cannabis produced. The law allows the commission to adjust the fee every year, capping it at a specific maximum as the market grows.

Although the commission has the authority to set and modify this fee, it can only recommend how the funds should be used, with final spending decisions falling on the governor and the Legislature. Part of the revenue must be directed toward initiatives that discourage youth from marijuana use.

The commission has conducted public talks on possible applications of the money over the last three years, coming up with ideas such as legal aid, expungement programs, social support services, and larger community reinvestment projects. None of the social equity fee funds have been used yet.

Proponents of the increase contend that without a larger fee, the program cannot have the desired effect. The American Civil Liberties Union of New Jersey’s Ami Kachalia also supports increasing the charge to the suggested $30 per ounce. She believes this adjustment would enhance the state’s commitment to social justice by funneling more resources into Latinx and Black communities, who faced the brunt of discriminatory drug enforcement policies.

Not all parties support the fee hike, as some worry it may harm the growing market. Raising the tax, they contend, would encourage growers to raise wholesale prices, which would then force retailers and manufacturers to pass the higher expenses on to customers. This might then encourage more individuals to buy cannabis from unlicensed vendors.

Cannabis firms, such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), operating in different markets will be hoping that any fees added onto marijuana products in New Jersey don’t make the final product too costly for the people to afford since this would be counterproductive to all parties concerned.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Why Cannabis Firms Need to Give Branding Adequate Attention

A troubling tendency has surfaced in states where marijuana markets are regulated: businesses frequently offer their goods using identical or very similar trademarks. This overlap occurs because the United States Patent and Trademark Office (USPTO) prohibits federal trademark safeguarding for cannabis products, as they are illegal at the federal level.

In the absence of federal trademark safeguards, marijuana businesses are left with little choice if they want to prevent others from using identical brand names or logos in different states.

This situation has created a unique issue in the sector where customers question if a product is from Company A or Company B when packaging or branding looks nearly identical. As more states implement regulated markets, new brands arise, raising the possibility of consumer confusion and underscoring the importance of unique trademarks.

Typically, marijuana businesses select a name or logo for their product, assuming it’s unique and unused by others, often without conducting a thorough search. Regrettably, this presumption may result in expensive legal disputes. Many marijuana business owners have encountered challenges over the years after discovering that their “unique” terminology, such as Dank, Emerald, Elevated, Canna, or 420, were already commonly used or connected to cannabis culture.

Businesses in the cannabis industry must therefore negotiate a challenging environment where trademark conflicts are inevitable until laws at the federal level change and the USPTO approves trademarks for marijuana products.

Once this happens, the shift will be both advantageous and difficult. The market will become more competitive as a result of the opening of the floodgates for new trademark applications, even though businesses will now have recourse to federal courts for trademark safeguarding.

In the interim, cannabis businesses should look at alternative brand protection strategies. Federally, trademarks are accessible for goods and services that do not directly involve the cannabis plant, such as select hemp-based goods, websites, smoking accessories, retail services, and non-infused products.

Cannabis companies can pursue trademark safeguarding in states where cannabis is regulated for their in-state offerings, like retail services, edibles, or flowers. However, these protections are limited to the state of registration, unlike federal trademarks, which cover the entire U.S., creating issues for companies that operate across state lines.

To further safeguard their brand, companies should consider other forms of intellectual property protection, such as patents, copyrights, or trade secrets.

One common misconception is that if a company hasn’t faced a trademark lawsuit yet, it won’t face one in the future. However, as the industry grows, litigation around trademark issues is expected to rise, with larger companies often leveraging their resources to protect their trademarks. When enforcement happens, smaller businesses may face the difficult choice between rebranding or engaging in a legal fight.

Many companies want the trademark to represent their product, but a more effective trademark reflects the company’s unique character, values, and purpose. A unique trademark enhances a brand’s long-term standing and helps it stand out in the marketplace.

It is also easier to defend, which makes it more difficult for rivals to violate the brand and guarantees greater recognition and protection.

With the proposed reclassification of cannabis to Schedule III and the evolving legal status of cannabinoids, more entrepreneurs are likely to enter the market, leading to a wave of new brands. In this dynamic landscape, a robust trademark is not just a logo—it protects a company’s identity. Starting early on trademark safeguarding can mean the difference between a smooth path to growth and facing costly legal obstacles.

For established companies like Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), protecting their brand identity is paramount since these entities have worked hard to get to where they currently are.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Scientific Review Finds Marijuana Lowers Chronic Nerve Pain

A recent review highlights the promising effects of cannabinoids, a compound in cannabis, in managing persistent nerve pain. According to the research, cannabinoids may offer substantial pain relief with few or no side effects, suggesting a valuable alternative to conventional pain medications for patients dealing with persistent nerve pain.

Published in the Cureus journal, the review underscores the positive impact of cannabinoids on pain control, noting their benefits as a more natural option compared to synthetic drugs. This could make cannabinoids an attractive option for people seeking alternatives to traditional medications.

The research team, which sifted through numerous studies, narrowed their focus to five randomized, placebo-controlled trials conducted from 2000 to 2024. Their findings show that patients receiving cannabinoid treatment reported significantly higher pain relief than those given a placebo.

According to the study, cannabinoids led to pain relief in about 33% of participants, compared to just 15% in the placebo group, as measured by an analogous analog scale. For individuals experiencing sharp, intense pain, using CBD in a topical form provided even more relief, based on a neural pain scale. Importantly, very few side effects were reported, underscoring cannabinoids’ potential advantages in pain treatment.

According to the study, for those suffering from neuropathic pain—a type of pain caused by nerve damage often related to HIV/AIDS, diabetes, multiple sclerosis, shingles, and sometimes as a side effect of specific medications or radiation—finding effective treatments is complex. Such conditions often require specialized care and intensive medication regimens. In this context, cannabinoids may represent a breakthrough in pain management, offering a potentially more accessible and natural alternative for long-term relief.

The researchers acknowledge that more data is needed to understand the long-term side effects and potential interactions of cannabinoids, particularly due to varying legal restrictions and societal attitudes worldwide. Despite these challenges, they point out that cannabinoids may offer a new approach to chronic pain treatment, standing out as a natural remedy with minimal adverse effects.

The study also calls for further clinical trials to determine the most effective formulations and dosages of marijuana-derived medications for managing chronic pain.

As medical cannabis continues to gain legal acceptance in various states, chronic pain is among the top reasons for its medical use. Reports from both healthcare providers and patients suggest that marijuana can be a powerful alternative for pain management, reinforcing the case for it to be more widely considered in pain treatment strategies.

Companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) that believe in the therapeutic potential of marijuana and its compounds will be pleased that many recent studies, such as this review, are confirming the medicinal attributes of marijuana.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Delaware Cannabis Business Sites Dwindle as Local Bans Take Effect

Last year, when Delaware legalized cannabis, legislators approved the opening of 30 retail cannabis stores across the state. However, despite licenses being expected this year and stores potentially launching by 2025, available locations for shoppers to purchase cannabis legally are declining.

Several cities and towns in the state have used a provision in the legalization law to ban marijuana retail outlets, along with testing, cultivation, and manufacturing facilities. Sussex County has enforced bans in towns such as Bridgeville, Seaford, Millsboro, and Dagsboro. Beach towns like Milton, Rehoboth, South Bethany, Dewey, Bethany, Lewes, Fenwick Island, and Ocean View have also opted out of allowing cannabis businesses.

Additionally, Middletown, Delaware’s fourth-biggest city, has passed a total ban on cannabis businesses, while Newark has made an exception for its Main Street shopping area. Dover, the second-biggest city in the state, is also considering limitations on where marijuana stores can operate.

Sussex County Council is utilizing another legal provision that enables counties to regulate aspects such as the number and location of cannabis businesses. The council has restricted cannabis stores to C3-zoned areas, which are designated for heavy commercial use. However, the law also prohibits any cannabis businesses from being within three miles of municipalities, churches, schools, or drug abuse treatment centers.

This zoning restriction effectively results in a ban on retail marijuana stores in the county since all of the C3-zoned areas are within three miles of restricted areas, leaving no viable locations for these businesses.

Meanwhile, in Wilmington, the mayor’s office issued a statement in September outlining its approach to cannabis businesses. Cannabis entrepreneurs would have little trouble opening their enterprises in different parts of the city if there were no local prohibitions.

The mayor, however, has expressed his intent to restrict cannabis businesses from operating near schools or neighborhoods. The proposal initially sought to ban these businesses within 100 feet of schools or residential areas. Permitted zones would include manufacturing districts, downtown retail areas, and commercial centers. However, the restricted zone was extended by the city’s planning commission to 300 feet, but it will be reviewed again this month before the council makes a final decision.

In New Castle County, the only current restrictions being considered are that cannabis stores cannot operate within 1,000 feet of places like schools, daycare centers, churches, parks, government offices, or drug treatment centers.

State Representative Ed Osienski, who sponsored the cannabis regulatory and legalization bills, has expressed frustration with the actions taken by most local governments. He stated that the original intent of the law was to treat cannabis stores similarly to liquor stores, which are common throughout the state.

Meanwhile, Robert Coupe, Delaware’s cannabis commissioner, has remained focused on processing license applications while staying neutral on the local zoning issues. Coupe acknowledged the difficulties created by these local restrictions, especially in Sussex County, but also noted that New Castle and Kent counties seem to be imposing fewer hurdles for cannabis retailers.

While the situation in Delaware is still very much in flux, industry actors like SNDL Inc. (NASDAQ: SNDL) from around the country that hoped for widespread access to adult-use marijuana products by adults wishing to consume those products could be getting concerned by the restrictive actions of local authorities with regard to potential locations for cannabis businesses.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com